How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Prescription Drug Pricing and Access Healthy People 2030 Management of the Patient Protection and Affordable Care Act Reauthorization of the Patient-Centered Outcomes Research Institute Repeal and Replacement of the Affordable Care Act
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2019 · third_quarter · Q3
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model Increased utilization of home dialysis Extension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients Increased use of Kidney Discards for transplantation Access of medications under Medicare Part D Protected Classes Comments on proposed rule on ESRD Treatment Choices Model Comments on ESRD Prospective Payment System and Quality Incentive Program Comments on interpretive guidance Conditions of Participation for organ transplant programs Comments on proposed revisions for organ procurement organization Conditions of Coverage outcomes measures
Source: Senate LDA
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Prescription Drug Pricing and Access Healthy People 2030 Management of the Patient Protection and Affordable Care Act Reauthorization of the Patient-Centered Outcomes Research Institute Repeal and Replacement of the Affordable Care Act
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); funding for the National Living Donor Assistance Center; increased utilization of Kidney Discards Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Prescription Drug Pricing and Access Comments on Healthy People 2030 Management of the Patient Protection and Affordable Care Act Reauthorization of the Patient-Centered Outcomes Research Institute Repeal and Replacement of the Affordable Care Act
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Prescription Drug Pricing and Access Healthy People 2030 Management of the Patient Protection and Affordable Care Act Reauthorization of the Patient-Centered Outcomes Research Institute Repeal and Replacement of the Affordable Care Act
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); funding for the National Living Donor Assistance Center; increased utilization of Kidney Discards Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Prescription Drug Pricing and Access Comments on Healthy People 2030 Management of the Patient Protection and Affordable Care Act Reauthorization of the Patient-Centered Outcomes Research Institute Repeal and Replacement of the Affordable Care Act
Living Donor Protection Act of 2019
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Prescription Drug Pricing and Access Healthy People 2030 Management of the Patient Protection and Affordable Care Act Reauthorization of the Patient-Centered Outcomes Research Institute Repeal and Replacement of the Affordable Care Act
Living Donor Protection Act of 2017
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill Prescription Drug Pricing H.R. 2644 and S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Health and Human Services Million Hearts initiative Health and Human Services KidneyX initiative Comments on Patient Focused Drug Development Draft Guidance for Industry Comments on Physician-focused Payment Model Technical Advisory Committee preliminary review and model consideration process Management of the Patient Protection and Affordable Care Act Repeal and Replacement of Affordable Care Act
Living Donor Protection Act of 2017
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation and Management of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill Support for H.R. 2644 and S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Participation in the HHS Million Hearts initiative Participation in HHS KidneyX initiative
Living Donor Protection Act of 2017
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation and Management of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill Support for H.R. 2644, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Participation in the HHS Million Hearts initiative Comments to Dept. of Labor regarding Proposed Rule on ERISA Association Health Plans Comments to AHRQ regarding Chronic Kidney Disease Endpoints
Living Donor Protection Act of 2017
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill. Comments on proposed policies by the Organ Procurement and Transplantation Network and United Network for Organ Sharing. Prescription Drug Pricing H.R. 2644 and S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017. Health and Human Services Million Hearts initiative. Health and Human Services KidneyX initiative. Management of the Patient Protection and Affordable Care Act. Repeal and Replacement of Affordable Care Act.
Chronic Kidney Disease Improvement in Research and Treatment Act of 2017
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation and Management of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill Support for H.R. 2644 and S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Participation in the HHS Million Hearts initiative Participation in HHS KidneyX initiative
Chronic Kidney Disease Improvement in Research and Treatment Act of 2017
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation and Management of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill Support for H.R. 2644, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Participation in the HHS Million Hearts initiative Comments to Dept. of Labor regarding Proposed Rule on ERISA Association Health Plans Comments to AHRQ regarding Chronic Kidney Disease Endpoints
Chronic Kidney Disease Improvement in Research and Treatment Act of 2017
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill. Comments on proposed policies by the Organ Procurement and Transplantation Network and United Network for Organ Sharing. Prescription Drug Pricing H.R. 2644 and S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017. Health and Human Services Million Hearts initiative. Health and Human Services KidneyX initiative. Management of the Patient Protection and Affordable Care Act. Repeal and Replacement of Affordable Care Act.
Chronic Kidney Disease Improvement in Research and Treatment Act of 2017
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill Prescription Drug Pricing H.R. 2644 and S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Health and Human Services Million Hearts initiative Health and Human Services KidneyX initiative Comments on Patient Focused Drug Development Draft Guidance for Industry Comments on Physician-focused Payment Model Technical Advisory Committee preliminary review and model consideration process Management of the Patient Protection and Affordable Care Act Repeal and Replacement of Affordable Care Act
To amend title XVIII of the Social Security Act to create care management demonstration programs for chronic kidney disease under the Medicare program, and for other purposes.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867)and build support for a Senate companion bill Proposed Alternative Payment Model for Chronic Kidney Disease care Increased utilization of home kidney dialysis Medicare coverage of immunosuppressive drugs for kidney transplant recipients Increased utilization of kidney discards for transplantation
To amend title XVIII of the Social Security Act to create care management demonstration programs for chronic kidney disease under the Medicare program, and for other purposes.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867)and build support for a Senate companion bill Proposed Alternative Payment Model for Chronic Kidney Disease care Comments to CMS regarding Medicare Advantage and Part D Annual Notice and Call Letter Peer Mentoring collaboration with CMS
To amend title XVIII of the Social Security Act to create care management demonstration programs for chronic kidney disease under the Medicare program, and for other purposes.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867) Proposed Alternative Payment Model for Chronic Kidney Disease care Comments on ESRD Prospective Payment System and Quality Incentive Program proposed rule Comments on payment policies under the Physician Fee Schedule; Medicare Shared Savings Program; and Quality Payment Program Increased utilization of home kidney dialysis Medicare coverage of immunosuppressive drugs for kidney transplant recipients Increased utilization of kidney discards for transplantation
To amend title XVIII of the Social Security Act to create care management demonstration programs for chronic kidney disease under the Medicare program, and for other purposes.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867). Proposed Alternative Payment Model for Chronic Kidney Disease care. Comments on Efficiency and Transparency Transplant Conditions of Participation, including organ discards. Comments on Proposed Rule Making for Part B drugs. Medicare Part D Protected Classes status. Increased utilization of home kidney dialysis. Medicare coverage of immunosuppressive drugs for kidney transplant recipients.
Chronic Kidney Disease Improvement in Research and Treatment Act of 2017
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation and Management of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill Support for H.R. 2644 and S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Participation in the HHS Million Hearts initiative Participation in HHS KidneyX initiative
Chronic Kidney Disease Improvement in Research and Treatment Act of 2017
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill Prescription Drug Pricing H.R. 2644 and S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Health and Human Services Million Hearts initiative Health and Human Services KidneyX initiative Comments on Patient Focused Drug Development Draft Guidance for Industry Comments on Physician-focused Payment Model Technical Advisory Committee preliminary review and model consideration process Management of the Patient Protection and Affordable Care Act Repeal and Replacement of Affordable Care Act
Chronic Kidney Disease Improvement in Research and Treatment Act of 2017
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill. Comments on proposed policies by the Organ Procurement and Transplantation Network and United Network for Organ Sharing. Prescription Drug Pricing H.R. 2644 and S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017. Health and Human Services Million Hearts initiative. Health and Human Services KidneyX initiative. Management of the Patient Protection and Affordable Care Act. Repeal and Replacement of Affordable Care Act.
Living Donor Protection Act of 2017
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to support early detection and management of Chronic Kidney Disease Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a companion bill in the Senate Comments on establishment of FDA Office of Patient Affairs
Living Donor Protection Act of 2017
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation and Management of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill Comments on HHS Strategic Plan for 2018-2022 Support for H.R. 2644, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Participation in the HHS Million Hearts initiative
Living Donor Protection Act of 2017
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867) Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a companion bill in the Senate Support for H.R. 2644, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017
Living Donor Protection Act of 2017
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to support early detection and management of Chronic Kidney Disease Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a companion bill in the Senate
Chronic Kidney Disease Improvement in Research and Treatment Act of 2017
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867) Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a companion bill in the Senate Support for H.R. 2644, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017
Chronic Kidney Disease Improvement in Research and Treatment Act of 2017
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation and Management of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill Comments on HHS Strategic Plan for 2018-2022 Support for H.R. 2644, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Participation in the HHS Million Hearts initiative
To amend title XVIII of the Social Security Act to create care management demonstration programs for chronic kidney disease under the Medicare program, and for other purposes.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867)and build support for a Senate companion bill Submitted Alternative Payment Model proposal for CKD care to CMS and HHS Comments to CMS on Dialysis Facility Compare
To amend title XVIII of the Social Security Act to create care management demonstration programs for chronic kidney disease under the Medicare program, and for other purposes.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867) Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a companion bill in the Senate Support for H.R. 2644, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017
Chronic Kidney Disease Improvement in Research and Treatment Act of 2015
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation,including S. 2584 and H.R. 4616, "Living Donor Protection Act" S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease
Chronic Kidney Disease Improvement in Research and Treatment Act of 2015
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of Patient Protection and Affordable Care Act (including comments on inappropriate steering of individuals eligible for Medicare and Medicaid benefits to individual Marketplace plans) Initiatives to increase and facilitate organ transplantation,including S. 2584 and H.R. 4616, Living Donor Protection Act S. 598 and H.R. 1130, Chronic Kidney Disease Improvement in Research and Training Act Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease Insurance discrimination and Third Party Premium Assistance
Chronic Kidney Disease Improvement in Research and Treatment Act of 2015
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation,including S. 2584 and H.R. 4616, "Living Donor Protection Act" S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease
Chronic Kidney Disease Improvement in Research and Treatment Act of 2015
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of Patient Protection and Affordable Care Act (including comments on inappropriate steering of individuals eligible for Medicare and Medicaid benefits to individual Marketplace plans) Initiatives to increase and facilitate organ transplantation,including S. 2584 and H.R. 4616, Living Donor Protection Act S. 598 and H.R. 1130, Chronic Kidney Disease Improvement in Research and Training Act Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease Insurance discrimination and Third Party Premium Assistance
Living Donor Protection Act of 2016
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of Patient Protection and Affordable Care Act (including comments on inappropriate steering of individuals eligible for Medicare and Medicaid benefits to individual Marketplace plans) Initiatives to increase and facilitate organ transplantation,including S. 2584 and H.R. 4616, Living Donor Protection Act S. 598 and H.R. 1130, Chronic Kidney Disease Improvement in Research and Training Act Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease Insurance discrimination and Third Party Premium Assistance
Living Donor Protection Act of 2016
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation,including S. 2584 and H.R. 4616, "Living Donor Protection Act" S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease
Living Donor Protection Act of 2016
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation,including S. 2584 and H.R. 4616, "Living Donor Protection Act" S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease
Living Donor Protection Act of 2016
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of Patient Protection and Affordable Care Act (including comments on inappropriate steering of individuals eligible for Medicare and Medicaid benefits to individual Marketplace plans) Initiatives to increase and facilitate organ transplantation,including S. 2584 and H.R. 4616, Living Donor Protection Act S. 598 and H.R. 1130, Chronic Kidney Disease Improvement in Research and Training Act Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease Insurance discrimination and Third Party Premium Assistance
Expanding Seniors Receiving Dialysis Choice Act of 2016
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Chronic Kidney Disease payment and delivery of care reform Medicare Access and CHIP Reauthorization Act (MACRA)implementation Medicare Advantage Risk Adjustment Kidney disease quality measures H.R. 5659, ESRD Choice Act H.R. 6139, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act Comments on ESRD Prospective Payment System and Quality Incentive Program Comments on Physician Fees Schedule and MA Provider Network requirements Comments on Transplant Outcomes Measures and Organ Procurement Organization Reporting
Expanding Seniors Receiving Dialysis Choice Act of 2016
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Chronic Kidney Disease payment and delivery of care reform Kidney disease quality measures H.R. 5659, ESRD Choice Act H.R. 6139, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act Comments on Dialysis Facility Compare and Star Ratings Comments on Notice of Benefit and Payment Parameters
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2016
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Chronic Kidney Disease payment and delivery of care reform Medicare Access and CHIP Reauthorization Act (MACRA)implementation Medicare Advantage Risk Adjustment Kidney disease quality measures H.R. 5659, ESRD Choice Act H.R. 6139, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act Comments on ESRD Prospective Payment System and Quality Incentive Program Comments on Physician Fees Schedule and MA Provider Network requirements Comments on Transplant Outcomes Measures and Organ Procurement Organization Reporting
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2016
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Chronic Kidney Disease payment and delivery of care reform Kidney disease quality measures H.R. 5659, ESRD Choice Act H.R. 6139, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act Comments on Dialysis Facility Compare and Star Ratings Comments on Notice of Benefit and Payment Parameters
Living Donor Protection Act of 2016
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation,including S. 2584 and H.R. 4616, "Living Donor Protection Act" S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease
Living Donor Protection Act of 2016
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of Patient Protection and Affordable Care Act (including comments on inappropriate steering of individuals eligible for Medicare and Medicaid benefits to individual Marketplace plans) Initiatives to increase and facilitate organ transplantation,including S. 2584 and H.R. 4616, Living Donor Protection Act S. 598 and H.R. 1130, Chronic Kidney Disease Improvement in Research and Training Act Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease Insurance discrimination and Third Party Premium Assistance
Living Donor Protection Act of 2016
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of Patient Protection and Affordable Care Act (including comments on inappropriate steering of individuals eligible for Medicare and Medicaid benefits to individual Marketplace plans) Initiatives to increase and facilitate organ transplantation,including S. 2584 and H.R. 4616, Living Donor Protection Act S. 598 and H.R. 1130, Chronic Kidney Disease Improvement in Research and Training Act Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease Insurance discrimination and Third Party Premium Assistance
Living Donor Protection Act of 2016
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation,including S. 2584 and H.R. 4616, "Living Donor Protection Act" S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease
Chronic Kidney Disease Improvement in Research and Treatment Act of 2015
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of Patient Protection and Affordable Care Act (including comments on inappropriate steering of individuals eligible for Medicare and Medicaid benefits to individual Marketplace plans) Initiatives to increase and facilitate organ transplantation,including S. 2584 and H.R. 4616, Living Donor Protection Act S. 598 and H.R. 1130, Chronic Kidney Disease Improvement in Research and Training Act Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease Insurance discrimination and Third Party Premium Assistance
Chronic Kidney Disease Improvement in Research and Treatment Act of 2015
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation,including S. 2584 and H.R. 4616, "Living Donor Protection Act" S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease
Chronic Kidney Disease Improvement in Research and Treatment Act of 2015
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation,including S. 2584 and H.R. 4616, "Living Donor Protection Act" S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease
Chronic Kidney Disease Improvement in Research and Treatment Act of 2015
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of Patient Protection and Affordable Care Act (including comments on inappropriate steering of individuals eligible for Medicare and Medicaid benefits to individual Marketplace plans) Initiatives to increase and facilitate organ transplantation,including S. 2584 and H.R. 4616, Living Donor Protection Act S. 598 and H.R. 1130, Chronic Kidney Disease Improvement in Research and Training Act Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease Insurance discrimination and Third Party Premium Assistance
Chronic Kidney Disease Improvement in Research and Treatment Act of 2015
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease NIH Strategic Plan Framework
Chronic Kidney Disease Improvement in Research and Treatment Act of 2015
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease H.R. 6, "21st Century Cures Act" Comments on dietary guidelines Interoperability priorities for electronic health records
Chronic Kidney Disease Improvement in Research and Treatment Act of 2015
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Comments to FDA on Dietary Reference intakes Initiatives in support of early detection of Chronic Kidney Disease Comments on House Energy and Commerce Committee draft "21st Century Cures" initiative
Chronic Kidney Disease Improvement in Research and Treatment Act of 2015
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease H.R. 6, "21st Century Cures Act" Comments on dietary guidelines Interoperability priorities for electronic health records
Chronic Kidney Disease Improvement in Research and Treatment Act of 2015
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease
Chronic Kidney Disease Improvement in Research and Treatment Act of 2015
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease NIH Strategic Plan Framework
Chronic Kidney Disease Improvement in Research and Treatment Act of 2015
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease H.R. 6, "21st Century Cures Act" Comments on dietary guidelines Interoperability priorities for electronic health records
Chronic Kidney Disease Improvement in Research and Treatment Act of 2015
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Comments to FDA on Dietary Reference intakes Initiatives in support of early detection of Chronic Kidney Disease Comments on House Energy and Commerce Committee draft "21st Century Cures" initiative
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
S. 323 and H.R. 1428, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act" H.R. 4188, "Establishing Beneficiary Equity in the Hospital Readmission Program Act" H.R. 4814, "Chronic Kidney Disease Improvement in Research and Training Act of 2014" Comments on the Medicare prospective payment system for dialysis Comments on Medicare coverage of dialysis for hospice patients Comments regarding Medicare Advantage and Part D payment issues for kidney patients
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
S. 323 and H.R. 1428, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act H.R. 4188, "Establishing Beneficiary Equity in the Hospital Readmission Program Act" H.R. 4814, "Chronic Kidney Disease Improvement in Research and Treatment Act of 2014" Improving quality for kidney disease patients Comments regarding Medicare Advantage and Medicare Part D payment issues for kidney disease patients
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
S. 323 and H.R. 1428, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act" H.R. 4188, "Establishing Beneficiary Equity in the Hospital Readmission Program Act" Medicare Dialysis Five Star Rating proposal
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
S. 323 and H.R. 1428, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act Response to proposed rule to amend protected class status of immunosuppressive drugs under Medicare Part D Improving quality for kidney disease patients Comments regarding Medicare Advantage and Medicare Part D payment issues for kidney disease patients
Establishing Beneficiary Equity in the Hospital Readmission Program Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
S. 323 and H.R. 1428, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act" H.R. 4188, "Establishing Beneficiary Equity in the Hospital Readmission Program Act" Medicare Dialysis Five Star Rating proposal
Establishing Beneficiary Equity in the Hospital Readmission Program Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
S. 323 and H.R. 1428, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act" H.R. 4188, "Establishing Beneficiary Equity in the Hospital Readmission Program Act" H.R. 4814, "Chronic Kidney Disease Improvement in Research and Training Act of 2014" Comments on the Medicare prospective payment system for dialysis Comments on Medicare coverage of dialysis for hospice patients Comments regarding Medicare Advantage and Part D payment issues for kidney patients
Establishing Beneficiary Equity in the Hospital Readmission Program Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
S. 323 and H.R. 1428, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act H.R. 4188, "Establishing Beneficiary Equity in the Hospital Readmission Program Act" H.R. 4814, "Chronic Kidney Disease Improvement in Research and Treatment Act of 2014" Improving quality for kidney disease patients Comments regarding Medicare Advantage and Medicare Part D payment issues for kidney disease patients
Chronic Kidney Disease Improvement in Research and Treatment Act of 2014
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
S. 323 and H.R. 1428, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act" H.R. 4188, "Establishing Beneficiary Equity in the Hospital Readmission Program Act" H.R. 4814, "Chronic Kidney Disease Improvement in Research and Training Act of 2014" Comments on the Medicare prospective payment system for dialysis Comments on Medicare coverage of dialysis for hospice patients Comments regarding Medicare Advantage and Part D payment issues for kidney patients
Chronic Kidney Disease Improvement in Research and Treatment Act of 2014
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of the Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation, including H.R. 5263, "Living Donor Protection Act" H.R. 4814, "Chronic Kidney Disease Improvement in Research and Training Act of 2014" Comments to FDA regarding patient input on medical product discussion and patient-focused drug development Patient access to drug therapies
Chronic Kidney Disease Improvement in Research and Treatment Act of 2014
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
S. 323 and H.R. 1428, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act H.R. 4188, "Establishing Beneficiary Equity in the Hospital Readmission Program Act" H.R. 4814, "Chronic Kidney Disease Improvement in Research and Treatment Act of 2014" Improving quality for kidney disease patients Comments regarding Medicare Advantage and Medicare Part D payment issues for kidney disease patients
Living Donor Protection Act of 2014
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of the Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation, including H.R. 5263, "Living Donor Protection Act" H.R. 4814, "Chronic Kidney Disease Improvement in Research and Training Act of 2014" Comments to FDA regarding patient input on medical product discussion and patient-focused drug development Patient access to drug therapies
Living Donor Protection Act of 2014
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Implementation of the Patient Protection and Affordable Care Act; benefits and accessibility to care Initiatives to increase and facilitate organ transplantation H.R. 5263, "Living Donor Protection Act"
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
S. 323 and H.R. 1428, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act" H.R. 4188, "Establishing Beneficiary Equity in the Hospital Readmission Program Act" H.R. 4814, "Chronic Kidney Disease Improvement in Research and Training Act of 2014" Comments on the Medicare prospective payment system for dialysis Comments on Medicare coverage of dialysis for hospice patients Comments regarding Medicare Advantage and Part D payment issues for kidney patients
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
S. 323 and H.R. 1428, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act H.R. 4188, "Establishing Beneficiary Equity in the Hospital Readmission Program Act" H.R. 4814, "Chronic Kidney Disease Improvement in Research and Treatment Act of 2014" Improving quality for kidney disease patients Comments regarding Medicare Advantage and Medicare Part D payment issues for kidney disease patients
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
S. 323 and H.R. 1428, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act Response to proposed rule to amend protected class status of immunosuppressive drugs under Medicare Part D Improving quality for kidney disease patients Comments regarding Medicare Advantage and Medicare Part D payment issues for kidney disease patients
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
S. 323 and H.R. 1428, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act" H.R. 4188, "Establishing Beneficiary Equity in the Hospital Readmission Program Act" Medicare Dialysis Five Star Rating proposal
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
S. 323 and H.R. 1428, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
S. 323 and H.R. 1428, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act Agency meeting to discuss (1) Physician Quality Reporting System and (2) Accountable Care Organizations
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
S. 323 and H.R. 1428, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act Agency meeting to discuss (1) Physician Quality Reporting System and (2) Accountable Care Organizations
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
S. 323 and H.R. 1428, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Prescription Drug Pricing and Access Healthy People 2030 Management of the Patient Protection and Affordable Care Act Reauthorization of the Patient-Centered Outcomes Research Institute Repeal and Replacement of the Affordable Care Act
FY 2020 Appropriations for the Department of Health and Human Services (NIH, CDC, HRSA); Food and Drug Administration; Indian Health Service, Veterans Affairs, and Department of Defense
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2019 · second_quarter · Q2
FY 2020 Appropriations for the Department of Health and Human Services (NIH, CDC, HRSA); Food and Drug Administration; Indian Health Service, Veterans Affairs, and Department of Defense
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Prescription Drug Pricing and Access Healthy People 2030 Management of the Patient Protection and Affordable Care Act Reauthorization of the Patient-Centered Outcomes Research Institute Repeal and Replacement of the Affordable Care Act
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model Increased utilization of home dialysis Extension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients Increased use of Kidney Discards for transplantation Access of medications under Medicare Part D Protected Classes
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2019 · first_quarter · Q1
FY 2019 and FY 2020 Appropriations for the Department of Health and Human Services (NIH, CDC, HRSA); Food and Drug Administration; Indian Health Service, Veterans Affairs, and Department of Defense
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); funding for the National Living Donor Assistance Center; increased utilization of Kidney Discards Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Prescription Drug Pricing and Access Comments on Healthy People 2030 Management of the Patient Protection and Affordable Care Act Reauthorization of the Patient-Centered Outcomes Research Institute Repeal and Replacement of the Affordable Care Act
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model Increased utilization of home dialysis Extension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients Increased use of Kidney Discards for transplantation Access of medications under Medicare Part D Protected Classes Medicare Advantage Step Therapy Modification of ICD-10-CM Codes
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2018 · fourth_quarter · Q4
FY 2019 Appropriations for the Department of Health and Human Services (NIH, CDC, HRSA); Food and Drug Administration; Department of Veterans Affairs, Indian Health Service, Department of Defense (medical research)
Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867). Proposed Alternative Payment Model for Chronic Kidney Disease care. Comments on Efficiency and Transparency Transplant Conditions of Participation, including organ discards. Comments on Proposed Rule Making for Part B drugs. Medicare Part D Protected Classes status. Increased utilization of home kidney dialysis. Medicare coverage of immunosuppressive drugs for kidney transplant recipients.
Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill. Comments on proposed policies by the Organ Procurement and Transplantation Network and United Network for Organ Sharing. Prescription Drug Pricing H.R. 2644 and S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017. Health and Human Services Million Hearts initiative. Health and Human Services KidneyX initiative. Management of the Patient Protection and Affordable Care Act. Repeal and Replacement of Affordable Care Act.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2018 · third_quarter · Q3
FY 2019 Appropriations for the Department of Health and Human Services (NIH, CDC, HRSA); Food and Drug Administration; Department of Veterans Affairs, Indian Health Service, Department of Defense (medical research)
Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867) Proposed Alternative Payment Model for Chronic Kidney Disease care Comments on ESRD Prospective Payment System and Quality Incentive Program proposed rule Comments on payment policies under the Physician Fee Schedule; Medicare Shared Savings Program; and Quality Payment Program Increased utilization of home kidney dialysis Medicare coverage of immunosuppressive drugs for kidney transplant recipients Increased utilization of kidney discards for transplantation
Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill Prescription Drug Pricing H.R. 2644 and S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Health and Human Services Million Hearts initiative Health and Human Services KidneyX initiative Comments on Patient Focused Drug Development Draft Guidance for Industry Comments on Physician-focused Payment Model Technical Advisory Committee preliminary review and model consideration process Management of the Patient Protection and Affordable Care Act Repeal and Replacement of Affordable Care Act
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2018 · second_quarter · Q2
Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867)and build support for a Senate companion bill Proposed Alternative Payment Model for Chronic Kidney Disease care Increased utilization of home kidney dialysis Medicare coverage of immunosuppressive drugs for kidney transplant recipients Increased utilization of kidney discards for transplantation
Implementation and Management of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill Support for H.R. 2644 and S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Participation in the HHS Million Hearts initiative Participation in HHS KidneyX initiative
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2018 · first_quarter · Q1
FY 2018 and FY 2019 Appropriations for the Department of Health and Human Services (NIH, CDC, HRSA); Food and Drug Administration; Department of Veterans Affairs, Indian Health Service
Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867)and build support for a Senate companion bill Proposed Alternative Payment Model for Chronic Kidney Disease care Comments to CMS regarding Medicare Advantage and Part D Annual Notice and Call Letter Peer Mentoring collaboration with CMS
Implementation and Management of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill Support for H.R. 2644, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Participation in the HHS Million Hearts initiative Comments to Dept. of Labor regarding Proposed Rule on ERISA Association Health Plans Comments to AHRQ regarding Chronic Kidney Disease Endpoints
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2017 · fourth_quarter · Q4
Implementation and Management of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill Comments on HHS Strategic Plan for 2018-2022 Support for H.R. 2644, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Participation in the HHS Million Hearts initiative
Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867)and build support for a Senate companion bill Submitted Alternative Payment Model proposal for CKD care to CMS and HHS Comments to CMS on Dialysis Facility Compare
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2017 · third_quarter · Q3
Implementation of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867) Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a companion bill in the Senate Support for H.R. 2644, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017
Comments on End Stage Renal Disease Program Prospective Payment System and Quality Incentive Program Comments on proposed updates to CMS Quality Payment Program Comments on Physician Fee Schedule and Diabetes Prevention Program
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2017 · second_quarter · Q2
FY 2018 Appropriations for the Dept. of Health and Human Services, Food and Drug Administration, and Dept. of Veterans Affairs.
Comments on End Stage Renal Disease program Prospective Payment System Transitional Drug Add-on Payment Comments on Medicare Model Guidelines 7.0 Comments on Incident ESRD Clinical Episode Payment Model
Implementation of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to support early detection and management of Chronic Kidney Disease Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a companion bill in the Senate Comments on establishment of FDA Office of Patient Affairs
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2017 · first_quarter · Q1
Implementation of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to support early detection and management of Chronic Kidney Disease Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a companion bill in the Senate
Submitted comments on Interim Final Rule regarding Third Party Premium Payments Submitted comments on Medicare Advantage Advanced Notice and changes regarding the ESRD normalization Factor, restoring Chronic Kidney Disease risk adjustment payments for CKD Stage 3, and replacing the existing quality measure related to CKD detection in the MA Star ratings
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2016 · fourth_quarter · Q4
FY 2017 Appropriations for: Department of Health and Human Services Food and Drug Administration Centers for Disease Control and Prevention National Institutes of Health Heath Resources and Services Administration Veterans Affairs
Chronic Kidney Disease payment and delivery of care reform Kidney disease quality measures H.R. 5659, ESRD Choice Act H.R. 6139, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act Comments on Dialysis Facility Compare and Star Ratings Comments on Notice of Benefit and Payment Parameters
Implementation of Patient Protection and Affordable Care Act (including comments on inappropriate steering of individuals eligible for Medicare and Medicaid benefits to individual Marketplace plans) Initiatives to increase and facilitate organ transplantation,including S. 2584 and H.R. 4616, Living Donor Protection Act S. 598 and H.R. 1130, Chronic Kidney Disease Improvement in Research and Training Act Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease Insurance discrimination and Third Party Premium Assistance
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2016 · third_quarter · Q3
Comments on Proposed Rulemaking to permit full practice authority to Advanced Practice Registered Nurses
Implementation of Patient Protection and Affordable Care Act (including comments on inappropriate steering of individuals eligible for Medicare and Medicaid benefits to individual Marketplace plans) Initiatives to increase and facilitate organ transplantation,including S. 2584 and H.R. 4616, Living Donor Protection Act S. 598 and H.R. 1130, Chronic Kidney Disease Improvement in Research and Training Act Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease Insurance discrimination and Third Party Premium Assistance
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2016 · second_quarter · Q2
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation,including S. 2584 and H.R. 4616, "Living Donor Protection Act" S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease
FY 2017 Appropriations for: Department of Health and Human Services Food and Drug Administration Centers for Disease Control and Prevention National Institutes of Health Heath Resources and Services Administration
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2016 · first_quarter · Q1
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation,including S. 2584 and H.R. 4616, "Living Donor Protection Act" S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease
FY 2017 Appropriations for: Department of Health and Human Services Food and Drug Administration Centers for Disease Control and Prevention National Institutes of Health Heath Resources and Services Administration
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2015 · fourth_quarter · Q4
FY 2016 Appropriations for: Department of Health and Human Services Food and Drug Administration Centers for Disease Control and Prevention National Institutes of Health Heath Resources and Services Administration
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease
Medicare coverage of immunosuppressive drugs for kidney transplant recipients
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2015 · third_quarter · Q3
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease NIH Strategic Plan Framework
Comments on Physician Fee Schedule Comments on Prospective Payment System and Quality Incentive Program Medicare coverage of immunosuppressive drugs for kidney transplant recipients Comments regarding quality improvements for kidney patients
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2015 · second_quarter · Q2
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease H.R. 6, "21st Century Cures Act" Comments on dietary guidelines Interoperability priorities for electronic health records
Comments to CMS on Dialysis Facility Conditions for Coverage Medicare coverage of immunosuppressive drugs for kidney transplant recipients Comments regarding quality improvements for kidney patients
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2015 · first_quarter · Q1
Medicare Dialysis Five Star rating system Comments to CMS on Dialysis Facility Conditions for Coverage Medicare coverage of immunosuppressive drugs for kidney transplant recipients Comments regarding quality improvements for kidney patients
FY 2016 Appropriations for the following: Department of Health and Human Services Food and Drug Administration Centers for Disease Control and Prevention National Institutes of Health Heath Resources and Services Administration Indian Health Service
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Comments to FDA on Dietary Reference intakes Initiatives in support of early detection of Chronic Kidney Disease Comments on House Energy and Commerce Committee draft "21st Century Cures" initiative
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2014 · fourth_quarter · Q4
Implementation of the Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation, including H.R. 5263, "Living Donor Protection Act" H.R. 4814, "Chronic Kidney Disease Improvement in Research and Training Act of 2014" Comments to FDA regarding patient input on medical product discussion and patient-focused drug development Patient access to drug therapies
S. 323 and H.R. 1428, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act" H.R. 4188, "Establishing Beneficiary Equity in the Hospital Readmission Program Act" Medicare Dialysis Five Star Rating proposal
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2014 · third_quarter · Q3
Implementation of the Patient Protection and Affordable Care Act; benefits and accessibility to care Initiatives to increase and facilitate organ transplantation H.R. 5263, "Living Donor Protection Act"
S. 323 and H.R. 1428, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act" H.R. 4188, "Establishing Beneficiary Equity in the Hospital Readmission Program Act" H.R. 4814, "Chronic Kidney Disease Improvement in Research and Training Act of 2014" Comments on the Medicare prospective payment system for dialysis Comments on Medicare coverage of dialysis for hospice patients Comments regarding Medicare Advantage and Part D payment issues for kidney patients
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2014 · second_quarter · Q2
Comments on FDA food labeling
S. 323 and H.R. 1428, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act H.R. 4188, "Establishing Beneficiary Equity in the Hospital Readmission Program Act" H.R. 4814, "Chronic Kidney Disease Improvement in Research and Treatment Act of 2014" Improving quality for kidney disease patients Comments regarding Medicare Advantage and Medicare Part D payment issues for kidney disease patients
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2014 · first_quarter · Q1
S. 323 and H.R. 1428, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act Response to proposed rule to amend protected class status of immunosuppressive drugs under Medicare Part D Improving quality for kidney disease patients Comments regarding Medicare Advantage and Medicare Part D payment issues for kidney disease patients
Implementation of the Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2013 · fourth_quarter · Q4
Implementation of the Patient Protection and Affordable Care Act Initiative to increase and facilitate organ transplantation Comments regarding biosimilars naming
S. 323 and H.R. 1428, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act Agency meeting to discuss (1) Physician Quality Reporting System and (2) Accountable Care Organizations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2013 · third_quarter · Q3
Implementation of the Patient Protection and Affordable Care Act
S. 323 and H.R. 1428, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), SENATE
FY 2019 Appropriations for the Department of Health and Human Services (NIH, CDC, HRSA); Food and Drug Administration; Department of Veterans Affairs, Indian Health Service, Department of Defense
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE
FY 2018 Appropriations for the Deptartment of Health and Human Services (NIH, CDC, HRSA); Food and Drug Administration; Department of Veterans Affairs, Indian Health Service
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
FY 2018 Appropriations for the Deptartment of Health and Human Services (NIH, CDC, HRSA);Food and Drug Administration; and Department of Veterans Affairs
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
FY 17 Appropriation and FY 18 Appropriations for the Dept. of Health and Human Services, Food and Drug Administration, and Dept. of Veterans Affairs.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, Veterans Affairs, Dept of (VA), White House Office
FY 2017 Appropriations for: Department of Health and Human Services Food and Drug Administration Centers for Disease Control and Prevention National Institutes of Health Heath Resources and Services Administration
Chronic Kidney Disease payment and delivery of care reform Medicare Access and CHIP Reauthorization Act (MACRA)implementation Medicare Advantage Risk Adjustment Kidney disease quality measures H.R. 5659, ESRD Choice Act H.R. 6139, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act Comments on ESRD Prospective Payment System and Quality Incentive Program Comments on Physician Fees Schedule and MA Provider Network requirements Comments on Transplant Outcomes Measures and Organ Procurement Organization Reporting
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, Veterans Affairs, Dept of (VA), White House Office
Chronic Kidney Disease payment and delivery reform Medicare Access and CHIP Reauthorization Act (MACRA)implementation Medicare Advantage Risk Adjustment Kidney disease quality measures Third Party insurance premium payment Medicare coverage of immunosuppressive drugs for kidney transplant recipients
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, White House Office
Chronic Kidney Disease payment and delivery reform Comments on dialysis vascular access and transplant measures Comments on dialysis Five Star methodology Comments on Medicare Access and CHIP Reauthorization Act (MACRA) Third Party insurance premium payment Medicare coverage of immunosuppressive drugs for kidney transplant recipients
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
FY 2016 Appropriations for: Department of Health and Human Services Food and Drug Administration Centers for Disease Control and Prevention National Institutes of Health Heath Resources and Services Administration Indian Health Service
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
FY 2016 Appropriations for: Department of Health and Human Services Food and Drug Administration Centers for Disease Control and Prevention National Institutes of Health Heath Resources and Services Administration Indian Health Service
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Submitted comments on FDA food labeling
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE